Bonnie L. Smith

Associate

Paris + 33.1.56.59.46.60

Contact

Partager

Bonnie Smith exerce dans le domaine du droit des sociétés et des valeurs mobilières, en se concentrant sur les opérations réalisées sur les marchés de capitaux, en particulier concernant les aspects du droit boursier américain. Elle conseille les émetteurs et institutions financières sur un large éventail d’opérations transfrontalières, notamment les émissions de titres de capital ou de créances, les introductions en bourse (IPO), les programmes at-the-market (ATM), les U.S. shelf, les scissions (spin-offs), les placements publics et privés, et les doubles cotations.

Bonnie Smith conseille également les sociétés cotées sur les questions courantes de gouvernance d'entreprise et de conformité aux obligations d'information périodique et permanente en droit américain et français, y compris en matière environnementale, sociale et de gouvernance (ESG) et de plans d'intéressement et de rémunération en actions.

Bonnie Smith a notamment conseillé Sanofi, dans le cadre de sa conformité continue auprès de la SEC, de son programme U.S. shelf et des émissions obligataires associées ; Orange, dans le cadre d'une émission obligataire en 144A, de sa radiation de la cote du NYSE et de sa désinscription auprès de la SEC ; Innate Pharma, dans le cadre de sa conformité continue auprès de la SEC et de son programme ATM; et EDAP TMS, dans le cadre de sa conformité boursière et d'émissions de titres de capital. Bonnie Smith a également conseillé des émetteurs dans le cadre de diverses opérations sur les marchés de capitaux, notamment Cellectis, Carmat et le Royaume de Belgique, ainsi que sur la cotation d'EUROAPI (scission de Sanofi).

Avant de rejoindre Jones Day, Bonnie Smith a exercé au sein d’un cabinet d’avocats international à Paris.

Expérience

  • Orange completes US$6 billion Notes offering across five tranchesJones Day advised Orange, the global telecommunications and digital services provider, on an inaugural Rule 144A offering of US$6 billion of Notes across five tranches.
  • Sanofi successfully completes US$3 billion Notes offeringJones Day advised Sanofi, the global biopharma group, on its successful offering of US$3 billion public offering of Notes across five tranches.
  • Sanofi to separate its consumer healthcare business, OpellaJones Day acted as securities law counsel in the separation of Opella, Sanofi's consumer healthcare business, and the sale of a 50% controlling stake to CD&R.
  • Financial institutions complete benchmark €5 billion 3.450% OLO by Kingdom of BelgiumJones Day assisted the financial institutions in connection with the issuance of a 17-year benchmark €5 billion 3.450% OLO (the “OLO 104”) by the Kingdom of Belgium.
  • Innate Pharma S.A. receives up to $7.9 million investment from The Institute for Follicular Lymphoma InnovationJones Day advised Innate Pharma S.A. in connection with an up to $7.9 million investment from The Institute for Follicular Lymphoma Innovation (IFLI).
  • Orange voluntarily delists from NYSE by successful consent solicitation and voluntarily deregisters with U.S. Securities and Exchange CommissionJones Day advised Orange, S.A., a leading telecommunications operator and digital service provider serving 287 million customers, on its voluntary delisting of its American Depositary Shares from the New York Stock Exchange (“NYSE”) and voluntary deregistration from the U.S. Securities and Exchange Commission, including its successful consent solicitation in relation to its US$2.5 billion outstanding 30-year Notes due 2031.
  • Financial institutions complete benchmark €7 billion 2.70% OLO by Kingdom of BelgiumJones Day assisted the financial institutions in connection with the issuance of a five-year benchmark €7 billion 2.70% OLO (the “OLO 102”) by the Kingdom of Belgium.
  • Amadeus FiRe completes buyback tender offerJones Day advised Amadeus FiRe AG in connection with a public fixed price share buyback tender offer to its shareholders for acquiring own shares; the company, a German specialized personnel service provider, is listed on the Frankfurt Stock Exchange (Prime Standard).
  • Median Technologies completes €11.6 million equity fundraising and places €10 million convertible bond to U.S. investorJones Day represented Median Technologies SA in connection with its (i) equity fundraising of €11.6 million outside of the United States pursuant to Regulation S, including through a public offering in France to retail investors via the PrimaryBid website and a private placement through an accelerated bookbuilding process, and (ii) placement of a €10 million convertible bond to a U.S. investor.
  • OakNorth finances Heartwood CollectionJones Day advised OakNorth Bank plc on its financing for leading UK hospitality and pub group Heartwood Collection.
  • BNP Paribas, Bryan Garnier, and Natixis complete €141 million capital increase of CarbiosJones Day advised BNP Paribas, Bryan Garnier, and Natixis in connection with the €141 million capital increase with shareholders' preferential subscription rights of Carbios, a biotech company specialized in the development and industrialization of biological technologies used for plastic and textiles recycling.
  • Innate Pharma S.A. establishes at-the-market program for up to US$75 million in United StatesJones Day represented Innate Pharma S.A., as U.S. counsel, in connection with the establishment of a new at-the-market (ATM) program for up to US$75 million in the United States, including filing a prospectus with the U.S. Securities & Exchange Commission for registered shares on a Form F-3 shelf registration statement.
  • Voltalia completes €490 million capital increase with shareholders' preferential subscription rightsJones Day advised Voltalia S.A. in the €490 million capital increase with shareholders’ preferential subscription rights on the regulated market of Euronext in Paris.
  • EDAP completes follow-on public offering of American Depositary SharesJones Day represented EDAP TMS, a global leader in robotic energy-based therapies, in connection with its follow-on public offering of 3,066,667 American Depositary Shares (ADSs) on the Nasdaq Global Market.
  • Voltalia issues additional green bondsJones Day advised Voltalia in its offering of additional green bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs Vertes) due 2025 (the “New Bonds”) for a nominal amount of approximately €50 million (the “Offering”) fully fungible with the OCEANEs Vertes issued in January 2021 for a total nominal amount of approximately €200 million due on January 13, 2025, (the “Existing Bonds”).
  • Bryan Garnier & Co Limited, Natixis, and Portzamparc complete up to €124 million IPO of Lhyfe on EuronextJones Day represented Bryan Garnier & Co Limited, Natixis, and Portzamparc (BNP Paribas Group), as joint lead managers and joint bookrunners, in connection with the up to €124 million initial public offering of Lhyfe on the regulated market of Euronext in Paris.
    •

    May 2026 Newsletters

    International Capital Markets Update | Spring 2026

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.